NCS Testing Technology Co., Ltd. (SHE:300797)
China · Delayed Price · Currency is CNY 16.03
-0.04 (-0.25%)
May 8, 2026, 3:04 PM CST
NCS Testing Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 1,228 | 1,178 | 1,098 | 949.53 | 815.42 | 701.64 | |
Revenue Growth (YoY) | 10.43% | 7.29% | 15.60% | 16.45% | 16.22% | 19.84% |
Cost of Revenue | 634.44 | 610.94 | 588.65 | 507.41 | 436.65 | 382.83 |
Gross Profit | 593.9 | 566.81 | 509.02 | 442.13 | 378.77 | 318.8 |
Selling, General & Admin | 306.81 | 298.45 | 277.2 | 253.57 | 208.79 | 186.02 |
Research & Development | 177.32 | 170.29 | 130.29 | 102.61 | 101.34 | 59.31 |
Other Operating Expenses | -64.9 | -59.52 | -0.09 | -2.59 | -0.21 | -24.31 |
Operating Expenses | 419.23 | 409.21 | 415.13 | 358.34 | 315.83 | 224.01 |
Operating Income | 174.67 | 157.6 | 93.89 | 83.78 | 62.94 | 94.79 |
Interest Expense | - | - | -5.51 | -5.94 | -6.55 | -7.21 |
Interest & Investment Income | - | - | 1.38 | 3.19 | 1.42 | 1.06 |
Currency Exchange Gain (Loss) | - | - | -1.08 | -0.11 | 0.21 | -0.46 |
Other Non Operating Income (Expenses) | -7.03 | -3.57 | 0.8 | -2.04 | -0.95 | 3.18 |
EBT Excluding Unusual Items | 167.64 | 154.03 | 89.49 | 78.89 | 57.06 | 91.36 |
Gain (Loss) on Sale of Investments | -0.02 | -0.02 | -0.38 | -0.26 | -0.26 | -0.14 |
Gain (Loss) on Sale of Assets | -0 | -0 | 0.17 | - | 15.79 | - |
Asset Writedown | -8.5 | -8.6 | -0.08 | -0.42 | -1.58 | -0.37 |
Other Unusual Items | - | - | 41.03 | 25.88 | 24.13 | - |
Pretax Income | 159.11 | 145.4 | 130.24 | 104.1 | 95.14 | 90.85 |
Income Tax Expense | 11.01 | 9.48 | 8.94 | 3.18 | 1.33 | 6.68 |
Earnings From Continuing Operations | 148.1 | 135.93 | 121.3 | 100.92 | 93.81 | 84.17 |
Minority Interest in Earnings | 15.12 | 19.79 | 23.72 | 24.78 | 20.04 | 0.02 |
Net Income | 163.22 | 155.72 | 145.02 | 125.7 | 113.84 | 84.19 |
Net Income to Common | 163.22 | 155.72 | 145.02 | 125.7 | 113.84 | 84.19 |
Net Income Growth | 9.52% | 7.37% | 15.37% | 10.41% | 35.22% | 9.03% |
Shares Outstanding (Basic) | 381 | 378 | 376 | 375 | 372 | 372 |
Shares Outstanding (Diluted) | 383 | 380 | 376 | 376 | 373 | 372 |
Shares Change (YoY) | 1.54% | 1.08% | -0.02% | 0.89% | 0.21% | 0.01% |
EPS (Basic) | 0.43 | 0.41 | 0.39 | 0.34 | 0.31 | 0.23 |
EPS (Diluted) | 0.43 | 0.41 | 0.39 | 0.33 | 0.31 | 0.23 |
EPS Growth | 7.86% | 6.23% | 15.39% | 9.44% | 34.94% | 9.02% |
Free Cash Flow | 129.28 | 105.91 | -14.36 | -69.26 | -63.56 | -22.74 |
Free Cash Flow Per Share | 0.34 | 0.28 | -0.04 | -0.18 | -0.17 | -0.06 |
Dividend Per Share | - | - | 0.120 | 0.100 | 0.089 | 0.068 |
Dividend Growth | - | - | 20.00% | 11.98% | 31.32% | 219.25% |
Gross Margin | 48.35% | 48.13% | 46.37% | 46.56% | 46.45% | 45.44% |
Operating Margin | 14.22% | 13.38% | 8.55% | 8.82% | 7.72% | 13.51% |
Profit Margin | 13.29% | 13.22% | 13.21% | 13.24% | 13.96% | 12.00% |
Free Cash Flow Margin | 10.53% | 8.99% | -1.31% | -7.29% | -7.79% | -3.24% |
EBITDA | 252.77 | 232.5 | 156.01 | 127.87 | 91.38 | 119.17 |
EBITDA Margin | 20.58% | 19.74% | 14.21% | 13.47% | 11.21% | 16.98% |
D&A For EBITDA | 78.09 | 74.9 | 62.12 | 44.09 | 28.44 | 24.38 |
EBIT | 174.67 | 157.6 | 93.89 | 83.78 | 62.94 | 94.79 |
EBIT Margin | 14.22% | 13.38% | 8.55% | 8.82% | 7.72% | 13.51% |
Effective Tax Rate | 6.92% | 6.52% | 6.86% | 3.06% | 1.40% | 7.35% |
Revenue as Reported | - | - | 1,098 | 949.53 | 815.42 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.